Novel recombinant protein PK5-Gal-3C enhances the anti-tumor activity of T cells via binding with TRPV2
Guopeng Zhang, Wei Zhang, Xiaohuan Wei, Zhenyu Wang, Feitong Wang, Shishuo Sun, Haiheng Xu, Xiangye Liu, Qing Zhang, Xiaoge Gao · 2026
Read Novel recombinant protein PK5-Gal-3C enhances the anti-tumor activity of T cells via binding with TRPV2 by Guopeng Zhang, Wei Zhang, Xiaohuan Wei, Zhenyu Wang, Feitong Wang, Shishuo Sun, Haiheng Xu, Xiangye Liu, Qing Zhang, Xiaoge Gao (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13323775.txt.
Description
Guopeng Zhang and colleagues design a fused protein that boosts T cell tumour killing, in work from 2026. Adoptive T cell care needs stronger killer function to beat solid tumours. A built protein joins a plasminogen piece with a sugar binding piece from galectin.
The fused protein binds a heat sensing calcium channel on T cell surfaces. Binding opens calcium flow, which fires a growth switch that lifts killing power. Blocking the channel or the switch cut the protein gains in cell tests. Mice with tumours showed deeper T cell entry and stronger tumour control. Engineered cell therapy for solid tumours also gained from the protein.
Catalog record
| CREATOR | Guopeng Zhang, Wei Zhang, Xiaohuan Wei, Zhenyu Wang, Feitong Wang, Shishuo Sun, Haiheng Xu, Xiangye Liu, Qing Zhang, Xiaoge Gao |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 46 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |